OCULAR SURFACE ACADEMY
OCULAR SURFACE ACADEMY
OCULAR SURFACE ACADEMY
Innovation in dry eye disease diagnostics and therapeutics has increased dramatically in the last few years. Join Scott Schachter, OD, and Christopher Starr, MD, as they meet with the researchers behind each committee of the global dry eye consensus, TFOS DEWS II. Optometrists and ophthalmologists who want to start or ramp up their dry eye practice should tune in and subscribe, as each episode will feature clinical takeaways.
TFOS Next Workshop: A Lifestyle Epidemic: Ocular Surface Disease with David Sullivan, PhD, and Amy Gallant Sullivan
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. In the last episode, Dr. Sullivan and Amy Gallant Sullivan discuss the next workshop […]
Jun 17, 2021
19 min
Industry Spotlight: Azura
Dr. Schachter speaks with Azura Ophthalmics CEO Marc Gleeson about the company’s pipeline, which is focused on the development of ophthalmic keratolytics for the treatment of disorders affecting the lid margin and ocular surface. The novel approach targets hyperkeratinization and impaired lipid secretory function of […]
Jun 16, 2021
14 min
TFOS DEWS II Wrap Up with David Sullivan, PhD, and Amy Gallant Sullivan
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. In this penultimate episode of the series, Dr. Sullivan and Amy Gallant Sullivan provide […]
Jun 11, 2021
12 min
TFOS DEWS II Diagnostic Methodology with James Wolffsohn, BSc(Hons), PgCertHE, PgDipAdvClinOptom, MBA, PhD, PFHEA, FSB FAAO, FCOptom, FIACLE, FBCLA
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. In the diagnostic methodology episode, Dr. Wolffsohn explains the complexities involved in selecting specific […]
Jun 10, 2021
29 min
TFOS DEWS II Pain and Sensation-Part 2 with Anat Galor, MD, MSPH, and Pedram Hamrah, MD
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. In part 2 of the pain and sensation episode, Drs Galor and Hamrah talk […]
Jun 2, 2021
17 min
TFOS DEWS II Pain and Sensation-Part 1 with Anat Galor, MD, MSPH, and Pedram Hamrah, MD
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. In part 1 of this two part episode on pain and sensation, Drs. Galor […]
Jun 2, 2021
28 min
TFOS DEWS II Pathophysiology with Maria Markouli, PhD, BOptom(Hons)
Dr. Markouli explains that the goal of the pathophysiology committee was first, to understand the normal, healthy, ocular surface and adnexa before discussing the changes that occur in dry eye disease. A key point to come out of the pathophysiology workshop, she notes, is that […]
May 21, 2021
32 min
Industry Spotlight: Lacrimedics
Robert S. Herrick, MD, a corneal external disease specialist, cofounded Lacrimedics in 1983 and has developed many innovative products and procedures for dry eye disease. In this Industry Spotlight he discusses his journey to a greater understanding of lacrimal system dysfunction, the benefits of occlusion therapy, and the development of […]
May 10, 2021
24 min
TFOS DEWS II Management and Therapy With Lyndon Jones, PhD, DSc, FCOptom, FAAO, and Sophie X. Deng, MD, PhD
TFOS DEWS II is an epic global consensus on dry eye disease. Join us as we go through each section with the scientists behind the work. Find out more here: https://ocularsurfaceacademy.com. Drs Jones and Deng talk about the importance of clinical evidence to drive proper […]
Apr 19, 2021
48 min
Industry Spotlight: Allergan
Glen Curran, Vice President, Marketing, US Eyecare at Allergan discusses the merger with Abbvie and what it was like to go through the transition during the pandemic. He notes how smooth the process was and what Abbvie brings to the table: a focus on science […]
Apr 15, 2021
28 min
Load more